Avalo Therapeutics (AVTX) FCF Margin Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.38 Mn |
| Dec 31, 2024 | -2,263.00 |
| Sep 30, 2024 | -341,665.00 |
| Dec 31, 2023 | 47,584.00 |
| Sep 30, 2023 | -182,253.00 |
| Jun 30, 2023 | -107,539.00 |
| Mar 31, 2023 | -194,109.00 |
| Dec 31, 2022 | -13,981.00 |
| Sep 30, 2022 | 38,422.00 |
| Jun 30, 2022 | -72,347.00 |
| Mar 31, 2022 | -124,213.00 |
| Dec 31, 2021 | -785,198.00 |
| Sep 30, 2021 | -119,849.00 |
| Jun 30, 2021 | -56,478.00 |
| Mar 31, 2021 | -387,006.00 |
| Dec 31, 2020 | -82,606.00 |
| Sep 30, 2020 | -115,043.00 |
| Jun 30, 2020 | 47,535.00 |
| Mar 31, 2020 | 37,418.00 |
| Dec 31, 2019 | 175,584.00 |
| Sep 30, 2019 | 72,396.00 |
| Jun 30, 2019 | 8,428.00 |